Epidemiology of nonalcoholic fatty liver

Clinics in Liver Disease

Volumn 8, Issue 3, 2004, Pages 501-519

  Ruhl, Constance E ^a   Everhart, James E ^b  

^a SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LIVER ENZYME;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ETHNOLOGY; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; IMAGE ANALYSIS; IMAGING; INSULIN RESISTANCE; LIVER BIOPSY; LIVER INJURY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PATIENT; POPULATION RESEARCH; PREDICTION; PREVALENCE; RACE DIFFERENCE; RADIOGRAPHY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SAMPLE; SCREENING; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SYMPTOMATOLOGY;

ADULT; AGE FACTORS; AGED; ALANINE TRANSAMINASE; DEMOGRAPHY; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SEX FACTORS;

EID: 4344582117     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2004.04.008     Document Type: Review

References (71)

1. Flegal K.M., Carroll M.D., Ogden C.L., Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 288(14):2002;1723-1727
2. Flegal K.M., Carroll M.D., Kuczmarski R.J., Johnson C.L. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 22(1):1998;39-47
3. Ruhl C.E., Everhart J.E. Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology. 124(7):2003;1821-1829
4. Neuschwander-Tetri B.A., Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 37(5):2003;1202-1219
5. Falck-Ytter Y., Younossi Z.M., Marchesini G., McCullough A.J. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 21(1):2001;17-26
6. Mofrad P., Contos M.J., Haque M., Sargeant C., Fisher R.A., Luketic V.A., et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 37(6):2003;1286-1292
7. Garcia-Monzon C., Martin-Perez E., Iacono O.L., Fernandez-Bermejo M., Majano P.L., Apolinario A., et al. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol. 33(5):2000;716-724
8. Daniel S., Ben-Menachem T., Vasudevan G., Ma C.K., Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol. 94(10):1999;3010-3014
9. Skelly M.M., James P.D., Ryder S.D. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol. 35(2):2001;195-199
10. Clark J.M., Brancati F.L., Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 98(5):2003;960-967
11. Clark J.M., Brancati F.L., Diehl A.M. Nonalcoholic fatty liver disease. Gastroenterology. 122(6):2002;1649-1657
12. Prati D., Taioli E., Zanella A., Della Torre E., Butelli S., Del Vecchio E., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 137(1):2002;1-10
13. Saadeh S., Younossi Z.M., Remer E.M., Gramlich T., Ong J.P., Hurley M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 123(3):2002;745-750
14. Yajima Y., Ohta K., Narui T., Abe R., Suzuki H., Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med. 139(1):1983;43-50
15. Saverymuttu S.H., Joseph A.E., Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed). 292(6512):1986;13-15
16. Foster K.J., Dewbury K.C., Griffith A.H., Wright R. The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol. 53(629):1980;440-442
17. Sanford N.L., Walsh P., Matis C., Baddeley H., Powell L.W. Is ultrasonography useful in the assessment of diffuse parenchymal liver disease? Gastroenterology. 89(1):1985;186-191
18. Needleman L., Kurtz A.B., Rifkin M.D., Cooper H.S., Pasto M.E., Goldberg B.B. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. Am J Roentgenol. 146(5):1986;1011-1015
19. Celle G., Savarino V., Picciotto A., Magnolia M.R., Scalabrini P., Dodero M. Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques. Dig Dis Sci. 33(4):1988;467-471
20. Joseph A.E., Saverymuttu S.H., al-Sam S., Cook M.G., Maxwell J.D. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 43(1):1991;26-31
21. Graif M., Yanuka M., Baraz M., Blank A., Moshkovitz M., Kessler A., et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol. 35(5):2000;319-324
22. Mathiesen U.L., Franzen L.E., Aselius H., Resjo M., Jacobsson L., Foberg U., et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis. 34(7):2002;516-522
23. Nomura H., Kashiwagi S., Hayashi J., Kajiyama W., Tani S., Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med. 27(2):1988;142-149
24. Oshibuchi M., Nishi F., Sato M., Ohtake H., Okuda K. Frequency of abnormalities detected by abdominal ultrasound among Japanese adults. J Gastroenterol Hepatol. 6(2):1991;165-168
25. Ikai E., Ishizaki M., Suzuki Y., Ishida M., Noborizaka Y., Yamada Y. Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people. J Hum Hypertens. 9(2):1995;101-105
26. Yano E., Tagawa K., Yamaoka K., Mori M. Test validity of periodic liver function tests in a population of Japanese male bank employees. J Clin Epidemiol. 54(9):2001;945-951
27. Bellentani S., Tiribelli C., Saccoccio G., Sodde M., Fratti N., De Martin C., et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology. 20(6):1994;1442-1449
28. Bellentani S., Saccoccio G., Masutti F., Croce L.S., Brandi G., Sasso F., et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 132(2):2000;112-117
29. Shen L., Fan J.G., Shao Y., Zeng M.D., Wang J.R., Luo G.H., et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol. 9(5):2003;1106-1110
30. Wanless I.R., Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 12(5):1990;1106-1110
31. Hilden M., Christoffersen P., Juhl E., Dalgaard J.B. Liver histology in a 'normal' population-examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol. 12(5):1977;593-597
32. Underwood Ground K.E. Liver pathology in aircrew. Aviat Space Environ Med. 53(1):1982;14-18
33. Underwood Ground K.E. Prevalence of fatty liver in healthy male adults accidentally killed. Aviat Space Environ Med. 55(1):1984;59-61
34. Ludwig J., Viggiano T.R., McGill D.B., Oh B.J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 55(7):1980;434-438
35. Diehl A.M., Goodman Z., Ishak K.G. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 95(4):1988;1056-1062
36. Lee R.G. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol. 20(6):1989;594-598
37. Powell E.E., Cooksley W.G., Hanson R., Searle J., Halliday J.W., Powell L.W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 11(1):1990;74-80
38. Bacon B.R., Farahvash M.J., Janney C.G., Neuschwander-Tetri B.A. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. 107(4):1994;1103-1109
39. Angulo P., Keach J.C., Batts K.P., Lindor K.D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 30(6):1999;1356-1362
40. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., McCullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 116(6):1999;1413-1419
41. Hornboll P., Olsen T.S. Fatty changes in the liver: the relation to age, overweight and diabetes mellitus. Acta Pathol Microbiol Immunol Scand [A]. 90(3):1982;199-205
42. Ruhl C.E., Everhart J.E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 124(1):2003;71-79
43. Pinto H.C., Baptista A., Camilo M.E., Valente A., Saragoca A., de Moura M.C. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci. 41(1):1996;172-179
44. Laurin J., Lindor K.D., Crippin J.S., Gossard A., Gores G.J., Ludwig J., et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology. 23(6):1996;1464-1467
45. Teli M.R., James O.F., Burt A.D., Bennett M.K., Day C.P. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 22(6):1995;1714-1719
46. George D.K., Goldwurm S., MacDonald G.A., Cowley L.L., Walker N.I., Ward P.J., et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology. 114(2):1998;311-318
47. Harris M.I., Flegal K.M., Cowie C.C., Eberhardt M.S., Goldstein D.E., Little R.R., et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 21(4):1998;518-524
48. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 287(3):2002;356-359
49. Caldwell S.H., Harris D.M., Patrie J.T., Hespenheide E.E. Is NASH underdiagnosed among African Americans? Am J Gastroenterol. 97(6):2002;1496-1500
50. Santos L., Molina E.G., Jeffers L., Reddy R., Schiff E. Prevalence of nonalcoholic steatohepatitis among ethnic groups. Gastroenterology. 120:2001;A117
51. Kemmer N.M., McKinney K.H., Xiao S.Y., Singh H., Murray R., Abdo B., et al. High prevalence of NASH among Mexican American females with type II diabetes mellitus. Gastroenterology. 120:2001;A117
52. Squires R.H., Lopez M.J. Steatohepatitis is a serious condition in Hispanic children. Hepatology. 32:2000;418A
53. Andersen T., Gluud C. Liver morphology in morbid obesity: a literature study. Int J Obes. 8(2):1984;97-106
54. Andersen T., Christoffersen P., Gluud C. The liver in consecutive patients with morbid obesity: a clinical, morphological, and biochemical study. Int J Obes. 8(2):1984;107-115
55. Braillon A., Capron J.P., Herve M.A., Degott C., Quenum C. Liver in obesity. Gut. 26(2):1985;133-139
56. Klain J., Fraser D., Goldstein J., Peiser J., Avinoah E., Ovnat A., et al. Liver histology abnormalities in the morbidly obese. Hepatology. 10(5):1989;873-876
57. Silverman J.F., O'Brien K.F., Long S., Leggett N., Khazanie P.G., Pories W.J., et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol. 85(10):1990;1349-1355
58. Luyckx F.H., Desaive C., Thiry A., Dewe W., Scheen A.J., Gielen J.E., et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord. 22(3):1998;222-226
59. Marceau P., Biron S., Hould F.S., Marceau S., Simard S., Thung S.N., et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab. 84(5):1999;1513-1517
60. Dixon J.B., Bhathal P.S., O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 121(1):2001;91-100
61. Ioannou G.N., Weiss N.S., Kowdley K.V., Dominitz J.A. Is obesity a risk factor for cirrhosis-related death or hospitalization? a population-based cohort study. Gastroenterology. 125(4):2003;1053-1059
62. Kral J.G., Schaffner F., Pierson R.N. Jr., Wang J. Body fat topography as an independent predictor of fatty liver. Metabolism. 42(5):1993;548-551
63. Hsieh S.D., Yoshinaga H. Is there any difference in coronary heart disease risk factors and prevalence of fatty liver in subjects with normal body mass index having different physiques? Tohoku J Exp Med. 177(3):1995;223-231
64. Banerji M.A., Buckley M.C., Chaiken R.L., Gordon D., Lebovitz H.E., Kral J.G. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord. 19(12):1995;846-850
65. Assy N., Kaita K., Mymin D., Levy C., Rosser B., Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci. 45(10):2000;1929-1934
66. Foster K.J., Griffith A.H., Dewbury K., Price C.P., Wright R. Liver disease in patients with diabetes mellitus. Postgrad Med J. 56(661):1980;767-772
67. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 106(25):2002;3143-3421
68. Marchesini G., Brizi M., Morselli-Labate A.M., Bianchi G., Bugianesi E., McCullough A.J., et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 107(5):1999;450-455
69. Knobler H., Schattner A., Zhornicki T., Malnick S.D., Keter D., Sokolovskaya N., et al. Fatty liver - an additional and treatable feature of the insulin resistance syndrome. QJM. 92(2):1999;73-79
70. Cortez-Pinto H., Camilo M.E., Baptista A., De Oliveira A.G., De Moura M.C. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr. 18(6):1999;353-358
71. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 50(8):2001;1844-1850